Cargando…
Stable, compounded bedaquiline suspensions to support practical implementation of pediatric dosing in the field
BACKGROUND: Bedaquiline (BDQ) tablets are indicated as part of a combination regimen for the treatment of multidrug-resistant TB in adults, adolescents and children. A dispersible tablet formulation is now approved but is not currently available in all settings. The aim of this study was to develop...
Autores principales: | Taneja, R., Nahata, M. C., Scarim, J., Pande, P. G., Scarim, A., Hoddinott, G., Fourie, C. L., Jew, R. K., Schaaf, H. S., Garcia-Prats, A. J., Hesseling, A. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union Against Tuberculosis and Lung Disease
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983625/ https://www.ncbi.nlm.nih.gov/pubmed/36855042 http://dx.doi.org/10.5588/ijtld.22.0440 |
Ejemplares similares
-
Extemporaneously compounded liquid formulations of clofazimine
por: Taneja, R., et al.
Publicado: (2023) -
A novel home-based method for preparing suspensions of anti-TB drugs
por: Taneja, R., et al.
Publicado: (2023) -
Sugar and sugar-free liquid formulations of delamanid for patients with rifampicin-resistant TB
por: Taneja, R., et al.
Publicado: (2023) -
Comparison of pharmacokinetics and bioavailability of bedaquiline fumarate, benzoate and maleate in dogs
por: Jaw-Tsai, S., et al.
Publicado: (2023) -
Relative bioavailability of bedaquiline tablets suspended in water: Implications for dosing in children
por: Svensson, Elin M., et al.
Publicado: (2018)